ストックスクリーナーアプリを入手
0.58
3.57%
0.02
プレマーケット:
.60
0.02
+3.45%
前日終値:
$0.56
開ける：
$0.579
24時間の取引高:
103.30K
Relative Volume:
0.70
時価総額：
$81.24M
収益：
$133.93M
当期純損益:
$4.97M
株価収益率:
17.37
EPS:
0.0334
ネットキャッシュフロー:
$10.12M
1週間 パフォーマンス:
+4.92%
1か月 パフォーマンス:
+17.86%
6か月 パフォーマンス:
-27.32%
1年 パフォーマンス:
+15.45%
1日の値動き範囲:
$0.5702
$0.5923
1週間の範囲:
$0.516
$0.5923
52週間の値動き範囲:
$0.438
$0.95
Xtant Medical Holdings Inc Stock (XTNT) Company Profile
名前
Xtant Medical Holdings Inc
セクター
電話
406-388-0480
住所
664 Cruiser Lane, Belgrade, MT
Compare XTNT vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
XTNT
Xtant Medical Holdings Inc
|
0.58 | 81.24M | 133.93M | 4.97M | 10.12M | 0.0334 |
ABT
Abbott Laboratories
|
87.17 | 151.83B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 113.08B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 99.87B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 83.21B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 47.80B | 6.30B | 1.07B | 1.34B | 1.8406 |
Xtant Medical Holdings Inc Stock (XTNT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-12-05 | 開始されました | BTIG Research | Buy |
| 2018-11-15 | 繰り返されました | Maxim Group | Buy |
| 2018-02-14 | 繰り返されました | Maxim Group | Buy |
Xtant Medical Holdings Inc (XTNT) 最新ニュース
MSN Money - MSN
3 Promising Penny Stocks With Market Caps Under $200M - simplywall.st
Xtant Medical shares drop nearly 5% as weak 2026 outlook overshadows Q4 beat - MSN
Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Short Interest Down 67.8% in April - MarketBeat
Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results (PR Newswire) - Aktiellt
Xtant (XTNT) Stock Prediction | Xtant Medical posts 100% EPS surprise, beats loss estimatesTrending Buy Opportunities - Cổng thông tin điện tử tỉnh Lào Cai
Xtant (XTNT) Stock: Risks and Growth Potential | Q4 2025: Earnings Beat EstimatesOperating Income - Cổng thông tin điện tử tỉnh Lào Cai
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Xtant Medical (XTNT): Buy Rating and Growth Prospects Highlighted - GuruFocus
Xtant Medical Holdings, Inc. (XTNT) - Minichart
Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Sees Large Growth in Short Interest - MarketBeat
Xtant Medical acquires exclusive U.S. rights to HEMOBLAST Bellows By Investing.com - Investing.com Australia
Xtant Medical Holdings, Inc. and Dilon Technologies, Inc Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product - marketscreener.com
Xtant Medical Secures Exclusive U.S. Distribution Rights for Dilon’s HEMOBLAST Bellows Hemostatic Product and Expands Sales Team - Minichart
Xtant Medical Expands Portfolio with HEMOBLAST Distribution Deal - TipRanks
Xtant Medical acquires exclusive U.S. rights to HEMOBLAST Bellows - Investing.com
Xtant Medical (XTNT) pays $5M for exclusive U.S. HEMOBLAST rights, adds 20 sales staff - Stock Titan
Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product - PR Newswire
Breakout Move: Can Xtant Medical Holdings Inc outperform under higher oil pricesTrade Analysis Report & High Win Rate Trade Alerts - baoquankhu1.vn
Sentiment Watch: Is Xtant Medical Holdings Inc stock overvalued or fairly priced2026 EndofYear Setup & Smart Swing Trading Techniques - baoquankhu1.vn
Meme Stocks: Can Xtant Medical Holdings Inc deliver consistent dividends2026 Stock Rankings & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial - Financial Times
Craig-Hallum Maintains Buy on Xtant Medical Holdings, Inc. (XTNT) March 2026 - Meyka
XTNT PE Ratio & Valuation, Is XTNT Overvalued - Intellectia AI
XTNT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Craig-Hallum Maintains Buy on Xtant Medical (XTNT) March 18, 2026 - Meyka
Xtant Medical Earnings Call Highlights Profitability Turnaround - The Globe and Mail
Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results - Orthopedics This Week
Xtant Medical (NYSEAMERICAN:XTNT) Issues Quarterly Earnings Results - MarketBeat
Xtant Medical Holdings, Inc. (AMEX:XTNT) Q4 2025 Earnings Call Transcript - Insider Monkey
Xtant Medical Achieves Profitability and 14% Revenue Growth in 2025, Provides 2026 Outlook After Strategic Divestiture - Minichart
Xtant Medical (NYSEAMERICAN:XTNT) Price Target Cut to $1.00 by Analysts at BTIG Research - Defense World
Xtant outlines $95M-$99M 2026 revenue outlook as Companion Spine divestiture and Q-code license revenue roll off - msn.com
Latest XTNT NewsXtant Medical Announces Debt Restructuring - Stock Titan
Xtant Medical Holdings, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
XTNT Stock Update: Analyst Lowers Price Target Amid Buy Rating | - GuruFocus
Xtant Medical Q4 2025 Earnings Call Transcript - MarketBeat
Xtant Medical Holdings, Inc. 2025 Annual Report: Orthobiologics, Spinal Implants, and Company Overview - Minichart
Xtant Medical Holdings, Inc. Provides Earnings Guidance for the Full Year 2026 - marketscreener.com
XTNT: 2025 saw double-digit revenue growth and profitability, with 2026 focused on core biologics acceleration - TradingView — Track All Markets
American Shared Hospital Services (AMS) Reports Q4 Earnings - news.alphastreet.com
Xtant Medical Holdings, Inc. (XTNT) Reports In-Line Q4 Earnings - AlphaStreet
Xtant Medical Holdings 2025 10-K: $133.9M Revenue, $0.03 Diluted EPS - TradingView
XTNT: 2025 net income of $5.0M driven by one-time gains; 2026 outlook pressured by lost license revenue - TradingView — Track All Markets
Xtant Medical (NYSE: XTNT) sheds one-time 2025 gains, sells Coflex/CoFix assets - Stock Titan
Xtant Medical Holdings reports FY2025 revenue $133.9M, net income $5.0M and adjusted EBITDA $16.3M - TradingView
XTNT: 2025 saw 14% revenue growth, profitability, and a strategic shift to core biologics - TradingView — Track All Markets
Form 8-KCurrent report - ADVFN
Xtant Medical Holdings, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Xtant Medical Holdings Inc (XTNT) 財務データ
収益
当期純利益
現金流量
EPS
0.41%
0.93%
大文字化:
|
ボリューム (24 時間):